← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nevada Cancer Institute
Las Vegas, NV
$13,703,325
Total funding
22
Grants
Funding over time
peak $5.1M · FY2005–11$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,497,542 · 15
DOD$3,839,884 · 3
CDC$886,899 · 2
DOE$479,000 · 2
By mechanism
R01$6,911,582 · 10
—$4,318,884 · 5
H75$886,899 · 2
R21$776,000 · 3
K01$428,697 · 1
K08$381,263 · 1
Investigators at Nevada Cancer Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
NEW RADIATION THERAPY SYSTEMS: APPLICATIONS TO HUMAN CANCER TREATMENT AND NOVEL DRUG DISCOVERY$2,245,000
· FY2008 · Department of the Army
IBRP-PREVENTION OF RADIATION INJURY BY THE USE OF STATINS$1,460,000
· FY2009 · Department of the Army
CANCER EDUCATION AND OUTREACH SERVICES FOR NEVADA: A PROGRAM TO PROVIDE A VARIETY$600,000
H75 · FY2010 · DP
A High-Throughput Model for Human Melanoma$513,524
R01 · FY2009 · CA
THE STEM CELL MARKER SALL4 AND CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PROSTATE CANCER PROGNOSES AND THERAPEUTICS$479,000
· FY2008 · Department of Energy
A mouse model of myelodysplastic syndrome progression and leukemic stem cells$450,000
R01 · FY2009 · HL
A mouse model of myelodysplastic syndrome progression and leukemic stem cells$450,000
R01 · FY2008 · HL
Biosensor Chip for Venous Thromboembolism Genotyping$358,997
R01 · FY2004 · HL
Biosensor Chip for Venous Thromboembolism Genotyping$338,528
R01 · FY2005 · HL
Ras Peptide Aptamers$337,007
R01 · FY2009 · CA
Ras Peptide Aptamers$337,007
R01 · FY2008 · CA
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells$336,150
R01 · FY2010 · CA
Biosensor Chip for Venous Thromboembolism Genotyping$330,573
R01 · FY2006 · HL
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells$326,066
R01 · FY2011 · CA
Biosensor Chip for Venous Thromboembolism Genotyping$320,985
R01 · FY2007 · HL
Role of Uridine Phosphorylase in Cancer Treatment$307,117
R01 · FY2008 · CA
Role of Uridine Phosphorylase in Cancer Treatment$297,095
R01 · FY2007 · CA
Role of Uridine Phosphorylase in Cancer Treatment$287,904
R01 · FY2006 · CA
POPULATION SCIENCES PROGRAM TO REDUCE INCIDENCE AND MORTALITY OF CANCERS IN NEVAD$286,899
H75 · FY2008 · DP
Free-Breathing Perfusion MRI of the Abdomen with Predictive Motion Correction$278,505
R01 · FY2011 · CA